BlackRock Global Allocation Fund
BlackRock Global Allocation Fund MDLOX Peers
See (MDLOX) competitors and their performances in Stock Market.
Peer Comparison Table: Asset Management - Global Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MDLOX | $19.99 | N/A | 16.4B | N/A | N/A | N/A |
| APO | $134.53 | +1.08% | 76.9B | 23.48 | $5.73 | +1.40% |
| SGIIX | $76.51 | +0.07% | 60B | 18.28 | $4.19 | N/A |
| FEGRX | $76.55 | +0.07% | 60B | 18.28 | $4.19 | N/A |
| FESGX | $72.28 | +0.07% | 59.7B | 18.26 | $3.96 | N/A |
| SGENX | $75.98 | +0.08% | 59.7B | 18.28 | $4.16 | N/A |
| APO-PA | $71.84 | +1.11% | 41.1B | 8.63 | $8.32 | +1.40% |
| GBLEX | $39.13 | +0.08% | 26.9B | 20.26 | $1.93 | N/A |
| AGVEX | $25.48 | +0.04% | 16.6B | 25.45 | $1.00 | N/A |
| FSGGX | $16.67 | +0.06% | 12.1B | N/A | N/A | N/A |
Stock Comparison
MDLOX vs APO Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, APO has a market cap of 76.9B. Regarding current trading prices, MDLOX is priced at $19.99, while APO trades at $134.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas APO's P/E ratio is 23.48. In terms of profitability, MDLOX's ROE is N/A, compared to APO's ROE of +0.21%. Regarding short-term risk, MDLOX is less volatile compared to APO. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.
MDLOX vs SGIIX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, SGIIX has a market cap of 60B. Regarding current trading prices, MDLOX is priced at $19.99, while SGIIX trades at $76.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas SGIIX's P/E ratio is 18.28. In terms of profitability, MDLOX's ROE is N/A, compared to SGIIX's ROE of N/A. Regarding short-term risk, MDLOX and SGIIX have similar daily volatility (0.00).
MDLOX vs FEGRX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, FEGRX has a market cap of 60B. Regarding current trading prices, MDLOX is priced at $19.99, while FEGRX trades at $76.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas FEGRX's P/E ratio is 18.28. In terms of profitability, MDLOX's ROE is N/A, compared to FEGRX's ROE of N/A. Regarding short-term risk, MDLOX and FEGRX have similar daily volatility (0.00).
MDLOX vs FESGX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, FESGX has a market cap of 59.7B. Regarding current trading prices, MDLOX is priced at $19.99, while FESGX trades at $72.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas FESGX's P/E ratio is 18.26. In terms of profitability, MDLOX's ROE is N/A, compared to FESGX's ROE of N/A. Regarding short-term risk, MDLOX and FESGX have similar daily volatility (0.00).
MDLOX vs SGENX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, SGENX has a market cap of 59.7B. Regarding current trading prices, MDLOX is priced at $19.99, while SGENX trades at $75.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas SGENX's P/E ratio is 18.28. In terms of profitability, MDLOX's ROE is N/A, compared to SGENX's ROE of N/A. Regarding short-term risk, MDLOX and SGENX have similar daily volatility (0.00).
MDLOX vs APO-PA Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, APO-PA has a market cap of 41.1B. Regarding current trading prices, MDLOX is priced at $19.99, while APO-PA trades at $71.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas APO-PA's P/E ratio is 8.63. In terms of profitability, MDLOX's ROE is N/A, compared to APO-PA's ROE of +0.21%. Regarding short-term risk, MDLOX is less volatile compared to APO-PA. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.
MDLOX vs GBLEX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, GBLEX has a market cap of 26.9B. Regarding current trading prices, MDLOX is priced at $19.99, while GBLEX trades at $39.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas GBLEX's P/E ratio is 20.26. In terms of profitability, MDLOX's ROE is N/A, compared to GBLEX's ROE of N/A. Regarding short-term risk, MDLOX and GBLEX have similar daily volatility (0.00).
MDLOX vs AGVEX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, AGVEX has a market cap of 16.6B. Regarding current trading prices, MDLOX is priced at $19.99, while AGVEX trades at $25.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas AGVEX's P/E ratio is 25.45. In terms of profitability, MDLOX's ROE is N/A, compared to AGVEX's ROE of N/A. Regarding short-term risk, MDLOX and AGVEX have similar daily volatility (0.00).
MDLOX vs FSGGX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, FSGGX has a market cap of 12.1B. Regarding current trading prices, MDLOX is priced at $19.99, while FSGGX trades at $16.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas FSGGX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to FSGGX's ROE of N/A. Regarding short-term risk, MDLOX and FSGGX have similar daily volatility (0.00).
MDLOX vs GLFOX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, GLFOX has a market cap of 10B. Regarding current trading prices, MDLOX is priced at $19.99, while GLFOX trades at $17.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas GLFOX's P/E ratio is 18.45. In terms of profitability, MDLOX's ROE is N/A, compared to GLFOX's ROE of N/A. Regarding short-term risk, MDLOX and GLFOX have similar daily volatility (0.00).
MDLOX vs GLIFX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, GLIFX has a market cap of 10B. Regarding current trading prices, MDLOX is priced at $19.99, while GLIFX trades at $17.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas GLIFX's P/E ratio is 18.47. In terms of profitability, MDLOX's ROE is N/A, compared to GLIFX's ROE of N/A. Regarding short-term risk, MDLOX and GLIFX have similar daily volatility (0.00).
MDLOX vs AAM-PB Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, AAM-PB has a market cap of 8.8B. Regarding current trading prices, MDLOX is priced at $19.99, while AAM-PB trades at $25.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas AAM-PB's P/E ratio is 40.26. In terms of profitability, MDLOX's ROE is N/A, compared to AAM-PB's ROE of +0.21%. Regarding short-term risk, MDLOX is less volatile compared to AAM-PB. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.
MDLOX vs AAM-PA Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, AAM-PA has a market cap of 8.8B. Regarding current trading prices, MDLOX is priced at $19.99, while AAM-PA trades at $25.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas AAM-PA's P/E ratio is 40.26. In terms of profitability, MDLOX's ROE is N/A, compared to AAM-PA's ROE of +0.21%. Regarding short-term risk, MDLOX is less volatile compared to AAM-PA. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.
MDLOX vs QYLD Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, QYLD has a market cap of 8.3B. Regarding current trading prices, MDLOX is priced at $19.99, while QYLD trades at $16.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas QYLD's P/E ratio is 30.80. In terms of profitability, MDLOX's ROE is N/A, compared to QYLD's ROE of N/A. Regarding short-term risk, MDLOX is less volatile compared to QYLD. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.
MDLOX vs PAVE Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, PAVE has a market cap of 8.1B. Regarding current trading prices, MDLOX is priced at $19.99, while PAVE trades at $42.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas PAVE's P/E ratio is 22.54. In terms of profitability, MDLOX's ROE is N/A, compared to PAVE's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to PAVE. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.
MDLOX vs VHGEX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, VHGEX has a market cap of 7.7B. Regarding current trading prices, MDLOX is priced at $19.99, while VHGEX trades at $37.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas VHGEX's P/E ratio is 21.35. In terms of profitability, MDLOX's ROE is N/A, compared to VHGEX's ROE of +0.00%. Regarding short-term risk, MDLOX and VHGEX have similar daily volatility (0.00).
MDLOX vs JATIX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, JATIX has a market cap of 7.4B. Regarding current trading prices, MDLOX is priced at $19.99, while JATIX trades at $68.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JATIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JATIX's ROE of N/A. Regarding short-term risk, MDLOX and JATIX have similar daily volatility (0.00).
MDLOX vs JAGTX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, JAGTX has a market cap of 7.4B. Regarding current trading prices, MDLOX is priced at $19.99, while JAGTX trades at $66.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JAGTX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JAGTX's ROE of N/A. Regarding short-term risk, MDLOX and JAGTX have similar daily volatility (0.00).
MDLOX vs JNGTX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, JNGTX has a market cap of 7.4B. Regarding current trading prices, MDLOX is priced at $19.99, while JNGTX trades at $67.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JNGTX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JNGTX's ROE of N/A. Regarding short-term risk, MDLOX and JNGTX have similar daily volatility (0.00).
MDLOX vs JATNX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, JATNX has a market cap of 7.4B. Regarding current trading prices, MDLOX is priced at $19.99, while JATNX trades at $67.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JATNX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JATNX's ROE of N/A. Regarding short-term risk, MDLOX and JATNX have similar daily volatility (0.00).
MDLOX vs JATSX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, JATSX has a market cap of 7.4B. Regarding current trading prices, MDLOX is priced at $19.99, while JATSX trades at $61.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JATSX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JATSX's ROE of N/A. Regarding short-term risk, MDLOX and JATSX have similar daily volatility (0.00).
MDLOX vs JATAX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, JATAX has a market cap of 7.4B. Regarding current trading prices, MDLOX is priced at $19.99, while JATAX trades at $63.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JATAX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JATAX's ROE of N/A. Regarding short-term risk, MDLOX and JATAX have similar daily volatility (0.00).
MDLOX vs JAGCX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, JAGCX has a market cap of 7.3B. Regarding current trading prices, MDLOX is priced at $19.99, while JAGCX trades at $51.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JAGCX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JAGCX's ROE of N/A. Regarding short-term risk, MDLOX and JAGCX have similar daily volatility (0.00).
MDLOX vs DFGEX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, DFGEX has a market cap of 7B. Regarding current trading prices, MDLOX is priced at $19.99, while DFGEX trades at $10.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas DFGEX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to DFGEX's ROE of N/A. Regarding short-term risk, MDLOX and DFGEX have similar daily volatility (0.00).
MDLOX vs PRGSX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, PRGSX has a market cap of 6.7B. Regarding current trading prices, MDLOX is priced at $19.99, while PRGSX trades at $65.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas PRGSX's P/E ratio is 26.72. In terms of profitability, MDLOX's ROE is N/A, compared to PRGSX's ROE of N/A. Regarding short-term risk, MDLOX and PRGSX have similar daily volatility (0.00).
MDLOX vs PAGSX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, PAGSX has a market cap of 6.7B. Regarding current trading prices, MDLOX is priced at $19.99, while PAGSX trades at $64.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas PAGSX's P/E ratio is 26.70. In terms of profitability, MDLOX's ROE is N/A, compared to PAGSX's ROE of N/A. Regarding short-term risk, MDLOX and PAGSX have similar daily volatility (0.00).
MDLOX vs PGGFX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, PGGFX has a market cap of 6.3B. Regarding current trading prices, MDLOX is priced at $19.99, while PGGFX trades at $24.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas PGGFX's P/E ratio is 24.19. In terms of profitability, MDLOX's ROE is N/A, compared to PGGFX's ROE of N/A. Regarding short-term risk, MDLOX and PGGFX have similar daily volatility (0.00).
MDLOX vs PRJQX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, PRJQX has a market cap of 6.3B. Regarding current trading prices, MDLOX is priced at $19.99, while PRJQX trades at $45.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas PRJQX's P/E ratio is 41.74. In terms of profitability, MDLOX's ROE is N/A, compared to PRJQX's ROE of N/A. Regarding short-term risk, MDLOX and PRJQX have similar daily volatility (0.00).
MDLOX vs PRJZX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, PRJZX has a market cap of 6.3B. Regarding current trading prices, MDLOX is priced at $19.99, while PRJZX trades at $45.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas PRJZX's P/E ratio is 41.74. In terms of profitability, MDLOX's ROE is N/A, compared to PRJZX's ROE of N/A. Regarding short-term risk, MDLOX and PRJZX have similar daily volatility (0.00).
MDLOX vs ACWV Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, ACWV has a market cap of 6B. Regarding current trading prices, MDLOX is priced at $19.99, while ACWV trades at $115.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas ACWV's P/E ratio is 18.47. In terms of profitability, MDLOX's ROE is N/A, compared to ACWV's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to ACWV. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.
MDLOX vs CGGO Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, CGGO has a market cap of 5.7B. Regarding current trading prices, MDLOX is priced at $19.99, while CGGO trades at $30.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas CGGO's P/E ratio is 23.16. In terms of profitability, MDLOX's ROE is N/A, compared to CGGO's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to CGGO. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.
MDLOX vs JDWNX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, JDWNX has a market cap of 5.1B. Regarding current trading prices, MDLOX is priced at $19.99, while JDWNX trades at $117.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JDWNX's P/E ratio is 16.12. In terms of profitability, MDLOX's ROE is N/A, compared to JDWNX's ROE of N/A. Regarding short-term risk, MDLOX and JDWNX have similar daily volatility (0.00).
MDLOX vs GUNR Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, GUNR has a market cap of 4.7B. Regarding current trading prices, MDLOX is priced at $19.99, while GUNR trades at $40.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas GUNR's P/E ratio is 16.05. In terms of profitability, MDLOX's ROE is N/A, compared to GUNR's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to GUNR. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.
MDLOX vs PRGTX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, PRGTX has a market cap of 4.4B. Regarding current trading prices, MDLOX is priced at $19.99, while PRGTX trades at $21.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas PRGTX's P/E ratio is 39.97. In terms of profitability, MDLOX's ROE is N/A, compared to PRGTX's ROE of +0.05%. Regarding short-term risk, MDLOX and PRGTX have similar daily volatility (0.00).
MDLOX vs IOO Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, IOO has a market cap of 4.4B. Regarding current trading prices, MDLOX is priced at $19.99, while IOO trades at $103.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas IOO's P/E ratio is 24.24. In terms of profitability, MDLOX's ROE is N/A, compared to IOO's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to IOO. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.
MDLOX vs JFNSX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, JFNSX has a market cap of 4.4B. Regarding current trading prices, MDLOX is priced at $19.99, while JFNSX trades at $61.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JFNSX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JFNSX's ROE of N/A. Regarding short-term risk, MDLOX and JFNSX have similar daily volatility (0.00).
MDLOX vs JFNCX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, JFNCX has a market cap of 4.4B. Regarding current trading prices, MDLOX is priced at $19.99, while JFNCX trades at $54.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JFNCX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JFNCX's ROE of N/A. Regarding short-term risk, MDLOX and JFNCX have similar daily volatility (0.00).
MDLOX vs JFNIX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, JFNIX has a market cap of 4.4B. Regarding current trading prices, MDLOX is priced at $19.99, while JFNIX trades at $65.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JFNIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JFNIX's ROE of N/A. Regarding short-term risk, MDLOX and JFNIX have similar daily volatility (0.00).
MDLOX vs JAGLX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, JAGLX has a market cap of 4.3B. Regarding current trading prices, MDLOX is priced at $19.99, while JAGLX trades at $64.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JAGLX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JAGLX's ROE of N/A. Regarding short-term risk, MDLOX and JAGLX have similar daily volatility (0.00).
MDLOX vs JNGLX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, JNGLX has a market cap of 4.3B. Regarding current trading prices, MDLOX is priced at $19.99, while JNGLX trades at $65.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JNGLX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JNGLX's ROE of N/A. Regarding short-term risk, MDLOX and JNGLX have similar daily volatility (0.00).
MDLOX vs JFNAX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, JFNAX has a market cap of 4.2B. Regarding current trading prices, MDLOX is priced at $19.99, while JFNAX trades at $63.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JFNAX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JFNAX's ROE of N/A. Regarding short-term risk, MDLOX and JFNAX have similar daily volatility (0.00).
MDLOX vs JFNNX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, JFNNX has a market cap of 4.2B. Regarding current trading prices, MDLOX is priced at $19.99, while JFNNX trades at $65.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JFNNX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JFNNX's ROE of N/A. Regarding short-term risk, MDLOX and JFNNX have similar daily volatility (0.00).
MDLOX vs JAWWX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, JAWWX has a market cap of 4.1B. Regarding current trading prices, MDLOX is priced at $19.99, while JAWWX trades at $117.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JAWWX's P/E ratio is 3.05. In terms of profitability, MDLOX's ROE is N/A, compared to JAWWX's ROE of N/A. Regarding short-term risk, MDLOX and JAWWX have similar daily volatility (0.00).
MDLOX vs JDWRX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, JDWRX has a market cap of 4.1B. Regarding current trading prices, MDLOX is priced at $19.99, while JDWRX trades at $117.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JDWRX's P/E ratio is 3.05. In terms of profitability, MDLOX's ROE is N/A, compared to JDWRX's ROE of N/A. Regarding short-term risk, MDLOX and JDWRX have similar daily volatility (0.00).
MDLOX vs JWWFX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, JWWFX has a market cap of 4.1B. Regarding current trading prices, MDLOX is priced at $19.99, while JWWFX trades at $120.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JWWFX's P/E ratio is 3.13. In terms of profitability, MDLOX's ROE is N/A, compared to JWWFX's ROE of N/A. Regarding short-term risk, MDLOX and JWWFX have similar daily volatility (0.00).
MDLOX vs JDWAX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, JDWAX has a market cap of 4.1B. Regarding current trading prices, MDLOX is priced at $19.99, while JDWAX trades at $119.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JDWAX's P/E ratio is 3.11. In terms of profitability, MDLOX's ROE is N/A, compared to JDWAX's ROE of N/A. Regarding short-term risk, MDLOX and JDWAX have similar daily volatility (0.00).
MDLOX vs JWWCX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, JWWCX has a market cap of 4.1B. Regarding current trading prices, MDLOX is priced at $19.99, while JWWCX trades at $113.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JWWCX's P/E ratio is 2.95. In terms of profitability, MDLOX's ROE is N/A, compared to JWWCX's ROE of N/A. Regarding short-term risk, MDLOX and JWWCX have similar daily volatility (0.00).
MDLOX vs JWGRX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, JWGRX has a market cap of 4B. Regarding current trading prices, MDLOX is priced at $19.99, while JWGRX trades at $119.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JWGRX's P/E ratio is 3.12. In terms of profitability, MDLOX's ROE is N/A, compared to JWGRX's ROE of N/A. Regarding short-term risk, MDLOX and JWGRX have similar daily volatility (0.00).
MDLOX vs REET Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, REET has a market cap of 3.9B. Regarding current trading prices, MDLOX is priced at $19.99, while REET trades at $24.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas REET's P/E ratio is 26.14. In terms of profitability, MDLOX's ROE is N/A, compared to REET's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to REET. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.
MDLOX vs CTYRX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, CTYRX has a market cap of 3.7B. Regarding current trading prices, MDLOX is priced at $19.99, while CTYRX trades at $92.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas CTYRX's P/E ratio is 37.78. In terms of profitability, MDLOX's ROE is N/A, compared to CTYRX's ROE of N/A. Regarding short-term risk, MDLOX and CTYRX have similar daily volatility (0.00).
MDLOX vs CTCAX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, CTCAX has a market cap of 3.6B. Regarding current trading prices, MDLOX is priced at $19.99, while CTCAX trades at $89.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas CTCAX's P/E ratio is 37.01. In terms of profitability, MDLOX's ROE is N/A, compared to CTCAX's ROE of N/A. Regarding short-term risk, MDLOX and CTCAX have similar daily volatility (0.00).
MDLOX vs CTHCX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, CTHCX has a market cap of 3.6B. Regarding current trading prices, MDLOX is priced at $19.99, while CTHCX trades at $75.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas CTHCX's P/E ratio is 36.98. In terms of profitability, MDLOX's ROE is N/A, compared to CTHCX's ROE of N/A. Regarding short-term risk, MDLOX and CTHCX have similar daily volatility (0.00).
MDLOX vs DGSIX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, DGSIX has a market cap of 3.6B. Regarding current trading prices, MDLOX is priced at $19.99, while DGSIX trades at $21.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas DGSIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to DGSIX's ROE of N/A. Regarding short-term risk, MDLOX and DGSIX have similar daily volatility (0.00).
MDLOX vs CTHRX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, CTHRX has a market cap of 3.6B. Regarding current trading prices, MDLOX is priced at $19.99, while CTHRX trades at $97.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas CTHRX's P/E ratio is 37.03. In terms of profitability, MDLOX's ROE is N/A, compared to CTHRX's ROE of N/A. Regarding short-term risk, MDLOX and CTHRX have similar daily volatility (0.00).
MDLOX vs CMTFX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, CMTFX has a market cap of 3.6B. Regarding current trading prices, MDLOX is priced at $19.99, while CMTFX trades at $94.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas CMTFX's P/E ratio is 37.02. In terms of profitability, MDLOX's ROE is N/A, compared to CMTFX's ROE of N/A. Regarding short-term risk, MDLOX and CMTFX have similar daily volatility (0.00).
MDLOX vs CGTUX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, CGTUX has a market cap of 3.5B. Regarding current trading prices, MDLOX is priced at $19.99, while CGTUX trades at $97.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas CGTUX's P/E ratio is 37.03. In terms of profitability, MDLOX's ROE is N/A, compared to CGTUX's ROE of N/A. Regarding short-term risk, MDLOX and CGTUX have similar daily volatility (0.00).
MDLOX vs VNQI Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, VNQI has a market cap of 3.5B. Regarding current trading prices, MDLOX is priced at $19.99, while VNQI trades at $44.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas VNQI's P/E ratio is 15.26. In terms of profitability, MDLOX's ROE is N/A, compared to VNQI's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to VNQI. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.
MDLOX vs BGHIX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, BGHIX has a market cap of 3.5B. Regarding current trading prices, MDLOX is priced at $19.99, while BGHIX trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas BGHIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to BGHIX's ROE of N/A. Regarding short-term risk, MDLOX and BGHIX have similar daily volatility (0.00).
MDLOX vs URA Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, URA has a market cap of 3.4B. Regarding current trading prices, MDLOX is priced at $19.99, while URA trades at $36.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas URA's P/E ratio is 28.21. In terms of profitability, MDLOX's ROE is N/A, compared to URA's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to URA. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.
MDLOX vs MGGIX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, MGGIX has a market cap of 3.3B. Regarding current trading prices, MDLOX is priced at $19.99, while MGGIX trades at $38.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas MGGIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to MGGIX's ROE of N/A. Regarding short-term risk, MDLOX and MGGIX have similar daily volatility (0.00).
MDLOX vs MGGPX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, MGGPX has a market cap of 3.3B. Regarding current trading prices, MDLOX is priced at $19.99, while MGGPX trades at $36.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas MGGPX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to MGGPX's ROE of N/A. Regarding short-term risk, MDLOX and MGGPX have similar daily volatility (0.00).
MDLOX vs XYLD Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, XYLD has a market cap of 3B. Regarding current trading prices, MDLOX is priced at $19.99, while XYLD trades at $38.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas XYLD's P/E ratio is 24.73. In terms of profitability, MDLOX's ROE is N/A, compared to XYLD's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to XYLD. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.
MDLOX vs IXJ Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, IXJ has a market cap of 3B. Regarding current trading prices, MDLOX is priced at $19.99, while IXJ trades at $84.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas IXJ's P/E ratio is 23.49. In terms of profitability, MDLOX's ROE is N/A, compared to IXJ's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to IXJ. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.
MDLOX vs GNR Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, GNR has a market cap of 2.8B. Regarding current trading prices, MDLOX is priced at $19.99, while GNR trades at $54.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas GNR's P/E ratio is 16.66. In terms of profitability, MDLOX's ROE is N/A, compared to GNR's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to GNR. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.
MDLOX vs LSWWX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, LSWWX has a market cap of 2.8B. Regarding current trading prices, MDLOX is priced at $19.99, while LSWWX trades at $25.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas LSWWX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to LSWWX's ROE of N/A. Regarding short-term risk, MDLOX and LSWWX have similar daily volatility (0.00).
MDLOX vs LGMAX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, LGMAX has a market cap of 2.8B. Regarding current trading prices, MDLOX is priced at $19.99, while LGMAX trades at $24.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas LGMAX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to LGMAX's ROE of N/A. Regarding short-term risk, MDLOX and LGMAX have similar daily volatility (0.00).
MDLOX vs LGMCX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, LGMCX has a market cap of 2.8B. Regarding current trading prices, MDLOX is priced at $19.99, while LGMCX trades at $23.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas LGMCX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to LGMCX's ROE of N/A. Regarding short-term risk, MDLOX and LGMCX have similar daily volatility (0.00).
MDLOX vs MSFBX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, MSFBX has a market cap of 2.7B. Regarding current trading prices, MDLOX is priced at $19.99, while MSFBX trades at $34.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas MSFBX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to MSFBX's ROE of +0.42%. Regarding short-term risk, MDLOX and MSFBX have similar daily volatility (0.00).
MDLOX vs MSFLX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, MSFLX has a market cap of 2.7B. Regarding current trading prices, MDLOX is priced at $19.99, while MSFLX trades at $33.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas MSFLX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to MSFLX's ROE of N/A. Regarding short-term risk, MDLOX and MSFLX have similar daily volatility (0.00).
MDLOX vs MLPX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, MLPX has a market cap of 2.6B. Regarding current trading prices, MDLOX is priced at $19.99, while MLPX trades at $62.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas MLPX's P/E ratio is 18.74. In terms of profitability, MDLOX's ROE is N/A, compared to MLPX's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to MLPX. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.
MDLOX vs CCHRX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, CCHRX has a market cap of 2.6B. Regarding current trading prices, MDLOX is priced at $19.99, while CCHRX trades at $87.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas CCHRX's P/E ratio is 27.66. In terms of profitability, MDLOX's ROE is N/A, compared to CCHRX's ROE of N/A. Regarding short-term risk, MDLOX and CCHRX have similar daily volatility (0.00).
MDLOX vs ARTGX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, ARTGX has a market cap of 2.6B. Regarding current trading prices, MDLOX is priced at $19.99, while ARTGX trades at $25.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas ARTGX's P/E ratio is 19.35. In terms of profitability, MDLOX's ROE is N/A, compared to ARTGX's ROE of N/A. Regarding short-term risk, MDLOX and ARTGX have similar daily volatility (0.00).
MDLOX vs APDGX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, APDGX has a market cap of 2.6B. Regarding current trading prices, MDLOX is priced at $19.99, while APDGX trades at $25.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas APDGX's P/E ratio is 19.36. In terms of profitability, MDLOX's ROE is N/A, compared to APDGX's ROE of N/A. Regarding short-term risk, MDLOX and APDGX have similar daily volatility (0.00).
MDLOX vs APHGX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, APHGX has a market cap of 2.5B. Regarding current trading prices, MDLOX is priced at $19.99, while APHGX trades at $25.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas APHGX's P/E ratio is 19.36. In terms of profitability, MDLOX's ROE is N/A, compared to APHGX's ROE of N/A. Regarding short-term risk, MDLOX and APHGX have similar daily volatility (0.00).
MDLOX vs VGWAX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, VGWAX has a market cap of 2.5B. Regarding current trading prices, MDLOX is priced at $19.99, while VGWAX trades at $33.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas VGWAX's P/E ratio is 16.18. In terms of profitability, MDLOX's ROE is N/A, compared to VGWAX's ROE of +0.00%. Regarding short-term risk, MDLOX and VGWAX have similar daily volatility (0.00).
MDLOX vs VGWLX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, VGWLX has a market cap of 2.5B. Regarding current trading prices, MDLOX is priced at $19.99, while VGWLX trades at $26.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas VGWLX's P/E ratio is 16.18. In terms of profitability, MDLOX's ROE is N/A, compared to VGWLX's ROE of +0.00%. Regarding short-term risk, MDLOX and VGWLX have similar daily volatility (0.00).
MDLOX vs NFRA Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, NFRA has a market cap of 2.5B. Regarding current trading prices, MDLOX is priced at $19.99, while NFRA trades at $60.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas NFRA's P/E ratio is 17.43. In terms of profitability, MDLOX's ROE is N/A, compared to NFRA's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to NFRA. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.
MDLOX vs BOTZ Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, BOTZ has a market cap of 2.5B. Regarding current trading prices, MDLOX is priced at $19.99, while BOTZ trades at $30.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas BOTZ's P/E ratio is 28.16. In terms of profitability, MDLOX's ROE is N/A, compared to BOTZ's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to BOTZ. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.
MDLOX vs JORIX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, JORIX has a market cap of 2.5B. Regarding current trading prices, MDLOX is priced at $19.99, while JORIX trades at $19.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JORIX's P/E ratio is 2.53. In terms of profitability, MDLOX's ROE is N/A, compared to JORIX's ROE of N/A. Regarding short-term risk, MDLOX and JORIX have similar daily volatility (0.00).
MDLOX vs JORAX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, JORAX has a market cap of 2.5B. Regarding current trading prices, MDLOX is priced at $19.99, while JORAX trades at $19.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JORAX's P/E ratio is 2.53. In terms of profitability, MDLOX's ROE is N/A, compared to JORAX's ROE of N/A. Regarding short-term risk, MDLOX and JORAX have similar daily volatility (0.00).
MDLOX vs DFGR Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, DFGR has a market cap of 2.5B. Regarding current trading prices, MDLOX is priced at $19.99, while DFGR trades at $26.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas DFGR's P/E ratio is 26.43. In terms of profitability, MDLOX's ROE is N/A, compared to DFGR's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to DFGR. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.
MDLOX vs JORFX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, JORFX has a market cap of 2.5B. Regarding current trading prices, MDLOX is priced at $19.99, while JORFX trades at $19.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JORFX's P/E ratio is 2.52. In terms of profitability, MDLOX's ROE is N/A, compared to JORFX's ROE of N/A. Regarding short-term risk, MDLOX and JORFX have similar daily volatility (0.00).
MDLOX vs JORNX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, JORNX has a market cap of 2.5B. Regarding current trading prices, MDLOX is priced at $19.99, while JORNX trades at $19.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JORNX's P/E ratio is 2.51. In terms of profitability, MDLOX's ROE is N/A, compared to JORNX's ROE of N/A. Regarding short-term risk, MDLOX and JORNX have similar daily volatility (0.00).
MDLOX vs JSLNX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, JSLNX has a market cap of 2.4B. Regarding current trading prices, MDLOX is priced at $19.99, while JSLNX trades at $19.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JSLNX's P/E ratio is 2.51. In terms of profitability, MDLOX's ROE is N/A, compared to JSLNX's ROE of N/A. Regarding short-term risk, MDLOX and JSLNX have similar daily volatility (0.00).
MDLOX vs FTGC Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, FTGC has a market cap of 2.4B. Regarding current trading prices, MDLOX is priced at $19.99, while FTGC trades at $25.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas FTGC's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to FTGC's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to FTGC. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.
MDLOX vs JORRX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, JORRX has a market cap of 2.4B. Regarding current trading prices, MDLOX is priced at $19.99, while JORRX trades at $19.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JORRX's P/E ratio is 2.46. In terms of profitability, MDLOX's ROE is N/A, compared to JORRX's ROE of N/A. Regarding short-term risk, MDLOX and JORRX have similar daily volatility (0.00).
MDLOX vs OPGIX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, OPGIX has a market cap of 2.4B. Regarding current trading prices, MDLOX is priced at $19.99, while OPGIX trades at $48.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas OPGIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to OPGIX's ROE of N/A. Regarding short-term risk, MDLOX and OPGIX have similar daily volatility (0.00).
MDLOX vs CSGZX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, CSGZX has a market cap of 2.3B. Regarding current trading prices, MDLOX is priced at $19.99, while CSGZX trades at $75.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas CSGZX's P/E ratio is 26.26. In terms of profitability, MDLOX's ROE is N/A, compared to CSGZX's ROE of N/A. Regarding short-term risk, MDLOX and CSGZX have similar daily volatility (0.00).
MDLOX vs SGTTX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, SGTTX has a market cap of 2.3B. Regarding current trading prices, MDLOX is priced at $19.99, while SGTTX trades at $76.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas SGTTX's P/E ratio is 26.26. In terms of profitability, MDLOX's ROE is N/A, compared to SGTTX's ROE of N/A. Regarding short-term risk, MDLOX and SGTTX have similar daily volatility (0.00).
MDLOX vs BIALX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, BIALX has a market cap of 2.3B. Regarding current trading prices, MDLOX is priced at $19.99, while BIALX trades at $28.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas BIALX's P/E ratio is 27.79. In terms of profitability, MDLOX's ROE is N/A, compared to BIALX's ROE of N/A. Regarding short-term risk, MDLOX and BIALX have similar daily volatility (0.00).
MDLOX vs JORCX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, JORCX has a market cap of 2.3B. Regarding current trading prices, MDLOX is priced at $19.99, while JORCX trades at $18.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JORCX's P/E ratio is 2.36. In terms of profitability, MDLOX's ROE is N/A, compared to JORCX's ROE of N/A. Regarding short-term risk, MDLOX and JORCX have similar daily volatility (0.00).
MDLOX vs GCOW Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, GCOW has a market cap of 2.3B. Regarding current trading prices, MDLOX is priced at $19.99, while GCOW trades at $37.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas GCOW's P/E ratio is 12.60. In terms of profitability, MDLOX's ROE is N/A, compared to GCOW's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to GCOW. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.
MDLOX vs PFFD Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, PFFD has a market cap of 2.3B. Regarding current trading prices, MDLOX is priced at $19.99, while PFFD trades at $18.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas PFFD's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to PFFD's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to PFFD. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.
MDLOX vs MWEFX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, MWEFX has a market cap of 2.2B. Regarding current trading prices, MDLOX is priced at $19.99, while MWEFX trades at $45.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas MWEFX's P/E ratio is 23.37. In terms of profitability, MDLOX's ROE is N/A, compared to MWEFX's ROE of N/A. Regarding short-term risk, MDLOX and MWEFX have similar daily volatility (0.00).
MDLOX vs IILGX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, IILGX has a market cap of 2.1B. Regarding current trading prices, MDLOX is priced at $19.99, while IILGX trades at $28.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas IILGX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to IILGX's ROE of N/A. Regarding short-term risk, MDLOX and IILGX have similar daily volatility (0.00).
MDLOX vs VMVFX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, VMVFX has a market cap of 2.1B. Regarding current trading prices, MDLOX is priced at $19.99, while VMVFX trades at $16.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas VMVFX's P/E ratio is 20.94. In terms of profitability, MDLOX's ROE is N/A, compared to VMVFX's ROE of +0.00%. Regarding short-term risk, MDLOX and VMVFX have similar daily volatility (0.00).
MDLOX vs VMNVX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, VMNVX has a market cap of 2.1B. Regarding current trading prices, MDLOX is priced at $19.99, while VMNVX trades at $33.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas VMNVX's P/E ratio is 20.96. In terms of profitability, MDLOX's ROE is N/A, compared to VMNVX's ROE of +0.00%. Regarding short-term risk, MDLOX and VMNVX have similar daily volatility (0.00).
MDLOX vs SGTRX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, SGTRX has a market cap of 2B. Regarding current trading prices, MDLOX is priced at $19.99, while SGTRX trades at $66.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas SGTRX's P/E ratio is 26.24. In terms of profitability, MDLOX's ROE is N/A, compared to SGTRX's ROE of N/A. Regarding short-term risk, MDLOX and SGTRX have similar daily volatility (0.00).
MDLOX vs ARTRX Comparison
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.4B. In comparison, ARTRX has a market cap of 2B. Regarding current trading prices, MDLOX is priced at $19.99, while ARTRX trades at $32.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas ARTRX's P/E ratio is 36.77. In terms of profitability, MDLOX's ROE is N/A, compared to ARTRX's ROE of N/A. Regarding short-term risk, MDLOX and ARTRX have similar daily volatility (0.00).